Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 subcutaneous E6011 in Japanese subjects with rheumatoid arthritis
jRCT2080222687Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of quetmolimab in rheumatoid arthritis (RA), sponsored by Eisai Co., Ltd. Started Dec 2014; status: completed.
02
Drugs
quetmolimab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080222687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222687.